Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I

(2010) Christine E. Staatz et al.   CLINICAL PHARMACOKINETICS

Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients

(2009) T Mori et al.   BONE MARROW TRANSPLANTATION

Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis

(2009) Hui-Hua Chang et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy

(2009) Alan R. Shuldiner   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient

(2009) D. Capone et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

(2008) G. M. Cooper et al.   BLOOD

Genotyping panel for assessing response to cancer chemotherapy

(2008) Zunyan Dai et al.   BMC Medical Genomics

Pharmacogenetics in Breast Cancer Therapy

(2008) S.-H. Tan et al.   CLINICAL CANCER RESEARCH